Therapeutic Asset Ratings
233 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cyclophosphamide
Stage IV Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P3
BBB
(74)
Epirubicin
Recurrent Breast Carcinoma
UNC Lineberger Comprehensive Cancer Center
P3
BBB
(74)
Everolimus
ER-positive Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P4
BBB
(73)
Inno-206
HIV Infections
UNC Lineberger Comprehensive Cancer Center
P4
BBB
(73)
Pembrolizumab
HER2/Neu Negative
UNC Lineberger Comprehensive Cancer Center
P2
BBB
(72)
Atezolizumab
Advanced Unresectable or Metastatic Solid Malignancy
UNC Lineberger Comprehensive Cancer Center
P2/3
BB
(71)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
HIV Infections
UNC Lineberger Comprehensive Cancer Center
P4
BB
(70)
Cyclophosphamide
Squamous Cell Carcinoma of the Lung
UNC Lineberger Comprehensive Cancer Center
P3
BB
(70)
Fludarabine
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
UNC Lineberger Comprehensive Cancer Center
P2
BB
(70)
Fludarabine
Nodal Marginal Zone B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
P2
BB
(70)
Namenda
Cognitive Change
UNC Lineberger Comprehensive Cancer Center
P4
BB
(69)
Namenda
Cognitive Impairment
UNC Lineberger Comprehensive Cancer Center
P3
BB
(69)
Cyclophosphamide
Estrogen Receptor-positive Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P2
BB
(68)
Everolimus
Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P4
BB
(67)
Bendamustine
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
P2
BB
(67)
Cyclophosphamide
Head and Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center
P4
BB
(66)
Epirubicin
Head and Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center
P4
BB
(66)
Pembrolizumab
Head and Neck Squamous Cell Carcinoma
UNC Lineberger Comprehensive Cancer Center
P4
BB
(66)
Fludarabine
Splenic Marginal Zone Lymphoma
UNC Lineberger Comprehensive Cancer Center
P3
BB
(66)
Bendamustine
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
UNC Lineberger Comprehensive Cancer Center
P2
BB
(66)
Everolimus
Stage IV Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P3
BB
(65)
Pembrolizumab
Squamous Cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center
P2
BB
(65)
Bendamustine
Nodal Marginal Zone B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
P2
BB
(64)
Bendamustine
Splenic Marginal Zone Lymphoma
UNC Lineberger Comprehensive Cancer Center
P2
BB
(64)
Brentuximab Vedotin
Adult T-Cell Leukemia/Lymphoma
UNC Lineberger Comprehensive Cancer Center
P2
BB
(64)
Showing 1 to 25 of 233 assets
Previous
Page 1 of 10
Next